2ZF-19608-50150
3 vaccinations
5 coded responses
18 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- American Indian or Alaska Native
- Ethnicity
- Hispanic or Latino
Timeline
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-28
Registered in v-safe
- 2020-12-28
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
- 2021-02-20
-
2021-02-23
Survey response — day 42, dose 2MedDRA: Cough, Pain, Pyrexia — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Mild fever, cough, body achesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — 3 months, dose 2MedDRA: Cough, Myalgia — Feeling: FairFree text: A lot of muscle ache and a mild coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-01-14
Dose 3 — Pfizer-BioNTech
-
2022-01-14
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, NauseaAdult check-in
-
2022-01-14
Survey response — 12 months, dose 2MedDRA: Cough, Dyspnoea, Fatigue, Palpitations, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Fever, fatigue, cough, sob, heart palpitationsMedDRA releases: 2024-11 · check-in free text available
- 2022-01-15
- 2022-01-17
- 2022-01-19
- 2022-01-20
-
2022-01-21
Health check-in — day 7, dose 3Feeling: Good · Headache, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
- 2022-02-03
- 2022-02-04
- 2022-02-11
-
2022-02-20
Survey response — day 35, dose 3MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: HeadachesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Survey response — day 42, dose 3MedDRA: Chest discomfort — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cheat pressureMedDRA releases: 2024-11 · check-in free text available
-
2022-02-25
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-25 | Unsuccessful |
Free text
Release 4 — day 42, dose 2
Symptoms: Mild fever, cough, body aches
Release 7 — 3 months, dose 2
Symptoms: A lot of muscle ache and a mild cough
Release 10 — 12 months, dose 2
Symptoms: Fever, fatigue, cough, sob, heart palpitations
Release 11 — day 35, dose 3
Symptoms: Headaches
Release 11 — day 42, dose 3
Symptoms: Cheat pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release